W.l.gore & Associates
Clinical trials sponsored by W.l.gore & Associates, explained in plain language.
-
New stent graft registry aims to track safety in real patients
Disease control Recruiting nowThis registry is following 240 people who receive the GORE VIABAHN VBX stent graft to treat blocked or damaged arteries in the abdomen, pelvis, or limbs. Researchers are tracking how well the device works and any serious side effects over time. The goal is to see if the stent gra…
Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jun 23, 2026 12:00 UTC
-
Synthetic cornea offers new hope for blurry vision
Disease control Recruiting nowThis study tests a new artificial cornea device for people whose vision is cloudy due to corneal damage. Ten participants who are eligible for a cornea transplant will receive the device and be followed for at least 12 months. The goal is to see if the device stays in place safel…
Phase: NA • Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jun 23, 2026 11:59 UTC
-
New hernia mesh under study: will it reduce recurrence?
Disease control Recruiting nowThis study is tracking 245 hernia patients who receive a GORE ENFORM absorbable mesh during surgery. Researchers will monitor hernia recurrence, infections, and other complications for up to two years. The goal is to see how well the mesh performs in real-world use for ventral, h…
Phase: NA • Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jun 23, 2026 11:57 UTC
-
New stent graft under scrutiny for aortic repair in japan
Disease control Recruiting nowThis study is checking how well a device called the GORE® TAG® Thoracic Branch Endoprosthesis works for people with a thoracic aortic aneurysm, dissection, or injury. About 200 patients in Japan who receive this stent graft will be followed to see if it is safe and effective. The…
Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jun 23, 2026 11:55 UTC
-
New stent graft could save lives from deadly aortic tear
Disease control Recruiting nowThis study tests a new device called the GORE ascending stent graft to treat a serious tear in the main artery from the heart (Type A aortic dissection). About 112 people with a recent tear will receive the stent graft through a small tube in a blood vessel, avoiding open-heart s…
Phase: NA • Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jun 22, 2026 12:09 UTC
-
New stent aims to keep leg arteries open longer
Disease control Recruiting nowThis study tests whether a fabric-covered stent (GORE VBX) works better than standard bare metal stents for people with severe blockages in the iliac arteries, which supply blood to the legs. About 244 participants with leg pain or tissue loss will be randomly assigned to receive…
Phase: NA • Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jun 22, 2026 11:59 UTC
-
New stent aims to restore blood flow in blocked leg veins
Disease control Recruiting nowThis study tests a new medical device called the GORE VIAFORT stent, which is a small mesh tube placed inside a blocked or narrowed vein in the leg or pelvis to keep it open. The goal is to improve blood flow and reduce symptoms like pain, swelling, and leg ulcers. About 165 adul…
Phase: NA • Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jun 18, 2026 11:51 UTC
-
New dialysis graft aims to keep blood flowing safely for kidney patients
Disease control Recruiting nowThis study tests a new device called the InnAVasc graft, which is placed under the skin to connect an artery and a vein for easy dialysis access. About 133 adults with end-stage kidney disease will receive the graft and be followed for 2 years. The main goals are to see if the gr…
Phase: NA • Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jun 16, 2026 12:51 UTC
-
New stent study aims to keep blood flowing in blocked aortic arteries
Disease control Recruiting nowThis study looks at how safe and effective a special stent (VBX) is for treating blocked arteries near the aorta in the lower belly. About 158 people who already had this stent placed at least a year ago will be followed. The goal is to see if the artery stays open and if there a…
Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jun 16, 2026 12:49 UTC
-
New stent device under watch for aortic aneurysm repair
Disease control Recruiting nowThis study is tracking how well a special stent device works for people with a bulging blood vessel (aneurysm) in the chest and belly area. About 100 patients will be followed for a year to see if the device stays in place, keeps blood flowing, and avoids serious problems like ru…
Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jun 15, 2026 19:07 UTC
-
10-Year study tracks stent graft safety in 1,500 aortic patients
Disease control Recruiting nowThis study follows 1,500 people who received a GORE® TAG® stent graft to treat aortic conditions like aneurysms or dissections. Researchers will monitor device performance and patient outcomes for up to 10 years. The goal is to confirm that this minimally invasive procedure remai…
Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jun 15, 2026 19:05 UTC
-
New stent graft for aortic arch disease tracked for 10 years
Disease control Recruiting nowThis study follows 125 people who received a special stent graft (GORE TAG TBE) to treat a tear or bulge in the main artery near the heart (aortic arch). The goal is to see how well the device works and how safe it is over 5 to 10 years. Participants are treated as part of their …
Phase: NA • Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jun 12, 2026 12:07 UTC
-
Heart hole closer may cut stroke risk in mystery cases
Disease control Recruiting nowThis study tests a device called GORE® CARDIOFORM Septal Occluder to close a small hole in the heart (PFO) in people who have had a stroke with no clear cause. About 636 participants will get the device plus blood-thinning medicine. The goal is to see if this reduces the chance o…
Phase: NA • Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jun 11, 2026 12:11 UTC
-
New device aims to improve breast reconstruction safety
Disease control Recruiting nowThis study tests a new medical device designed to reinforce breast reconstruction surgery after mastectomy. About 180 women having their first breast reconstruction will be enrolled, with some receiving the device and others having standard surgery without it. The goal is to see …
Phase: NA • Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jun 11, 2026 12:10 UTC
-
10-Year watch on aneurysm repair devices begins
Knowledge-focused Recruiting nowThis study follows 2000 people who have or will receive a GORE EXCLUDER stent-graft to repair an abdominal aortic aneurysm (AAA). Researchers will track device safety and performance over 10 years, checking for complications like leaks, movement, or kidney problems. The goal is t…
Sponsor: W.L.Gore & Associates • Aim: Knowledge-focused
Last updated Jun 18, 2026 11:48 UTC